fundvisualizer.com

RBC Global Equity Leaders IRGLIX

Performance (before sales charge)

As of 10/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2024
Stock
65.42%
Non-U.S. Stock
33.37%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.21%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2024

Basic materials

2.89%

Consumer cyclical

10.02%

Financial services

18.89%

Real estate

1.87%

Consumer defensive

9.14%

Health care

14.85%

Utilities

0.00%

Communication services

7.02%

Energy

2.42%

Industrials

7.97%

Technology

23.72%

Top 10 holdings

As of 09/30/2024

Microsoft Corp
6.11%
UnitedHealth Group Inc
4.81%
Amazon.com Inc
4.64%
Novo Nordisk AS Class B
4.19%
DBS Group Holdings Ltd
4.04%
HCA Healthcare Inc
4.03%
Safran SA
4.02%
Blackstone Inc
3.71%
Taiwan Semiconductor Manufacturing Co Ltd ADR
3.52%
Procter & Gamble Co
3.50%
Fund assets

$5.34 Million

Share class

Inst

Morningstar category

Global Large-Stock Growth

Expense ratio

0.75%

Investment objective

World Stock

Documents